Glenmark has launched the same under two brand names — Remo MV and Remozen MV.
The company got the regulatory approval in late September 2021.
Priced at Rs 16.50 per tablet, a diabetic patient has to take the tablet twice a day and cost per day works out to 53 per cent cheaper than other drugs.
READ RELATED: Lack of Vitamin D Does Not Raise the Risk of Type 1 Diabetes
According to Alok Malik, Group Vice President & Business Head, India Formulations, the fixed dose combination drug will significantly improve patient compliance and provide glycemic and extra glycemic benefits to patients with uncontrolled type 2 diabetes, in India.
Source: IANS
Source:
